OTC Markets OTCQB - Delayed Quote USD
Nuo Therapeutics, Inc. (AURX)
1.5000
+0.0200
+(1.35%)
As of April 23 at 4:00:00 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CLAUSEN PETER Chief Operating Officer | Stock Award(Grant) | May 20, 2024 | 589,675 |
| PITTMAN SCOTT M Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Nov 15, 2024 | 5,396,050 |
| SHEEDY CHARLES E Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 18, 2024 | 11,440,900 |
Related Tickers
MRES Institute of Biomedical Research Corp.
0.0165
-8.33%
ARTH Arch Therapeutics, Inc.
0.1608
0.00%
VXLLF Vaxil Bio Ltd.
0.0129
0.00%
THRD Third Harmonic Bio, Inc.
5.16
+0.10%
CUE Cue Biopharma, Inc.
0.8013
-4.19%
MDXG MiMedx Group, Inc.
6.80
+0.59%
CELU Celularity Inc.
1.7000
+5.59%
TCBPY TC Biopharm (Holdings) Plc
0.4500
+45.16%
NNVC NanoViricides, Inc.
1.3552
+1.62%
XFOR X4 Pharmaceuticals, Inc.
0.1832
-8.99%